When you say FY24, I am guessing you talking about FY24 starting Jan 24 to Dec 24 (American not the Australian) , same as company reporting.
If you talking Jan 24 to Dec 24 then the first quarter revenue is only $11m so basically within next 3 quarter you are expecting it to make $64m or $21m per quarter? The approval just came in end of May so basically second quarter almost finished (1 month left) so they technical has 2 quarter left to show the performance !
Now, that is challenging growth of almost 50% from last financial year revenue.
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-24
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.060(2.37%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.51 | $2.45 | $478.8K | 192.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |